News
The U.S. Food and Drug Administration on Thursday published more than 200 of its so-called complete response letters to drugmakers, a significant move to increase transparency of the agency's work.
5d
Axios on MSNZyn nicotine pouches: America's new addictive obsessionAxios Visuals It's not food, it's not chewing tobacco and it's not gum — though it might look like it when you see it — but it is becoming America's new addictive obsession. Why it matters: Sales of ...
Swedish Match, a subsidiary of Philip Morris International, makes the ZYN pouches. The FDA's authorization noted the pouches ...
CPEAR’s poll is a thinly veiled attempt to persuade policymakers to take a broadly popular issue in a less popular direction.
With its vast experience, Altria can provide Juul Labs support in legal battles regarding patent infringement6 7 and consumer health claims.8 9 With Juul Labs under pressure to respond to Food and ...
S&P 500 surges in H1 2025; explore AI leaders & ETFs for H2. Click to learn more about stocks to avoid and tips to navigate ...
R.J. Reynolds Vapor Co.’s Vuse remains the top-selling e-cigarette brand with a 34.9% market share, while Geek Bar Pule by ...
PRINCETON, N.J., June 27, 2025--U.S. FDA Approves Streamlined Patient Monitoring Requirements and Removal of REMS Programs within Bristol Myers Squibb’s Cell Therapy Labels ...
It could also be impactful now that the Food and Drug Administration has cracked down on Ozempic copycats, potentially slimming options for consumers who have come to rely on budget-friendly ...
LEXINGTON, Mass.-- (BUSINESS WIRE)-- Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced receipt of a Special Protocol Assessment Agreement Letter from the U.S. Food and Drug ...
Opinion
15dOpinion
Zacks Investment Research on MSNTop 3 Tobacco Stocks to Watch Amid Strong Industry Growth TrendsThe Zacks Tobacco industry is undergoing a strategic transformation, increasingly prioritizing smoke-free alternatives in response to rising consumer health awareness and tightening regulations on ...
Grace Therapeutics Announces Submission of New Drug Application to U.S. Food and Drug Administration for GTx-104 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results